Ansa Biotechnologies, Inc.
Ansa Biotechnologies, Inc., headquartered in the United States, is a pioneering force in the biotechnology industry, specialising in advanced DNA synthesis and genomic technologies. Founded in 2018, the company has rapidly established itself as a leader in synthetic biology, focusing on innovative solutions for research and therapeutic applications. Ansa Biotechnologies offers unique, high-fidelity DNA synthesis services that cater to a diverse range of sectors, including pharmaceuticals, agriculture, and environmental science. Their proprietary technology enables rapid and cost-effective production of custom DNA sequences, setting them apart in a competitive market. With a commitment to quality and precision, Ansa Biotechnologies has achieved significant milestones, positioning itself as a trusted partner for researchers and companies seeking cutting-edge biotechnological solutions.
DitchCarbon Score
How does Ansa Biotechnologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ansa Biotechnologies, Inc.'s score of 18 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ansa Biotechnologies, Inc.'s reported carbon emissions
In 2023, Ansa Biotechnologies, Inc. reported a commitment to significantly reduce its carbon emissions, targeting a reduction of approximately 48% in both Scope 1 and Scope 2 emissions by 2033. This ambitious goal reflects the company's long-term strategy to enhance sustainability and mitigate climate impact. While specific emissions data for 2023 is not disclosed, the company has established a clear framework for its climate commitments, focusing on absolute reductions in CO₂ emissions. The reduction targets are set to begin in 2023 and extend through to 2033, indicating a proactive approach to environmental responsibility. Ansa Biotechnologies, Inc. has not inherited emissions data from any parent company, ensuring that its climate commitments are independently defined. The company is on track to meet its two-year milestones, demonstrating a commitment to transparency and accountability in its environmental initiatives. Overall, Ansa Biotechnologies, Inc. is positioning itself as a responsible player in the biotechnology sector, with a clear focus on reducing its carbon footprint and contributing to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ansa Biotechnologies, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
